Q1 2023

Filed May 12, 2023 · 10-Q · 42 days after period end · 0001493152-23-016611

Q1 2023 · 10-Q

Revenue—

Net Income

-$268.82K

N/M vs Q1 2022

EPS Diluted

-$0.01

no prior Q1 2022 on file

Operating Income-$164,792N/M

Operating Cash Flow-$27,784N/M

Same quarter

Metric	Q1 2023	Q1 2022	Q1 2021	Q1 2013
Revenue	—	—	—	$81.06K
Net Income	-$268.82K	-$217.46K	-$212.59K	-$288.68K
EPS Diluted	-$0.01	—	—	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NovelStem International Corp. · CIK 912544 · Engraved from SEC EDGAR